Image by freepik The composition of gut bacteria can predict which melanoma patients will experience cancer recurrence after surgical resection and immunotherapy, but only when matched to patients with similar microbial profiles, according to research published April 17 in Cell. The findings from a 674-patient international clinical trial offer a novel approach to stratifying recurrence risk in high-risk melanoma patients undergoing adjuvant immune checkpoint blockade. Resear

Nerves (in green) within a melanoma tumour. Photo by: Dr. David J. Simon Nerve fibres within melanomas can slow tumour growth, according to a study led by Weill Cornell Medicine investigators. The findings help clarify the emerging field of cancer neuroscience and may inform future therapeutic strategies. In the study, published April 29 in Neuron, the researchers used mouse models of melanoma to examine the presence and the effects of peripheral nerves that grow into tumours

Melanoma cells with the cell membrane protein CD44 stained in red and the nucleus in blue. Dil-labelled extracellular vesicles taken up by cancer cells are shown in green. Image by Kaisa Mäki-Mantila. Pro-inflammatory macrophages may do more than mark an inflamed tumour microenvironment; they may help drive melanoma toward a more invasive phenotype, according to new data from the University of Eastern Finland. The findings, published in Cell Communication and Signaling , posi

Dr. Antoni Ribas, senior author of the study and director of the UCLA Health Jonsson Comprehensive Cancer Center’s Tumour Immunology...

The newly designed ExoPatch, being removed from a sample of mouse skin, successfully distinguished melanoma from healthy skin in mice. A...

A newly published study from NYU Langone Health and the Perlmutter Cancer Center suggests a promising avenue of treatment for patients...

A multinational study led by Yale School of Medicine and the Karolinska Institute in Sweden has found that artificial intelligence...

Elizabeth Burton, PhD. Photo courtesy The University of Texas MD Anderson Cancer Center In a significant advance for the management of...